Why Pfizer is ready to give Corona Vaccine in India without profit?

0
Pfizer-BioNTech-vaccine

New Delhi: The cases of coronavirus epidemic are increasing in the country. Every day frightening figures are coming out. The central government is giving a lot of emphasis on vaccines, tests, and treatment. Meanwhile, American pharmaceutical company Pfizer said that it has offered an unprofitable price to the Indian government for the corona vaccine. A spokesperson of the company claims that they are also in talks with the Government of India.

Pfizer’s spokesperson says, “The company has offered not for profit to the government of India for the vaccine. We are committed to providing vaccines to India. Let me tell you that there were many discussions about the price of the vaccine of the American vaccine company Pfizer amid the growing corona infection in India. The company has issued this statement, dismissing the media reports.

The company says that they have fixed different prices of the vaccine according to the income of the countries. He is committed to affordable and equal access to vaccines to all people. It is being said that in view of the increasing outbreak of Corona, India is intensifying vaccination further. Under which many foreign vaccines are also being cleared. It is being said that negotiations are also going on at the level of approval of Johnson & Johnson, Pfizer from the Government of India.

CStone, Pfizer

Vav will supply key ingredient of Kovid vaccine to Pfizer, Moderna
Explain that biopharma company VAV Lifesciences has signed an agreement for the supply of phospholipids. It is an important ingredient used in the manufacture of mRNA-based Covid-19. VAV has signed this agreement with the US contract development and manufacturing company. This company makes vaccines for multinationals like Pfizer-Biontech and Moderna.

Mumbai-based VAV Lifesciences is the only domestic company in the Covid-19 vaccine supply chain with this important ingredient. It can play an important role in the global mRNA-based vaccine supply chain. It will implement this agreement through its subsidiary VAV Lipids. VAV Lipids has tied up with the US contract development and manufacturing company.